![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer](https://www.roche.com/src/resources/images/favicon.ico)
Business
[Ad Hoc Announcement Pursuant To Art. 53 Lr] Roche Provides Update On Phase Iii Persevera Study In Er-Positive Advanced Breast Cancer
By Roche
persevERA Breast Cancer study did not meet the primary objective of a statistically significant improvement in progression-free survival, but a numerical improvement was observed
Giredestrant plus palbociclib was well tolerated and adverse events wer ...Read more
:max_bytes(150000):strip_icc()/GettyImages-22091330602-2696e765b3fa4ee19b828644506b119b.jpg)
